SpringWorks Therapeutics Inc (NAS:SWTX)
$ 36.12 -0.08 (-0.22%) Market Cap: 2.68 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 4.71 GF Score: 40/100

SpringWorks Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

Nov 29, 2022 / 09:20PM GMT
Release Date Price: $23.51 (+1.03%)
Umer Raffat
Evercore Inc. - Analyst

Hey, guys. Thanks for joining us. Pleasure to have the management team from SpringWorks join us. I know there's a lot of activity coming up in the coming months but let me turn it over to you first to kick things off.

Saqib Islam
SpringWorks Therapeutics, Inc. - CEO

Thanks, Umer. Obviously, we appreciate you hosting us today at your conference. It's a pleasure to be here to share updates on SpringWorks ahead of -- as you said, it will be a busy 12 months ahead of us with data across the portfolio and potentially a drug launch upcoming in 2023. Before going into specific questions, I'd love to start with a brief overview of SpringWorks.

For those who don't know us, we are a clinical-stage oncology company committed to making a profound impact on patients suffering from severe rare diseases and cancer. We're advancing a diversified pipeline spanning our three core focus areas, which are rare tumors, multiple myeloma through BCMA combinations, and biomarker-defined metastatic solid tumors.

Our late-stage

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot